Clinical updates, including trial initiations, enrollment status and data readouts and publications: ACM, Adamis, BMS, Enanta, Gilead, Lynk, Novo, Ovoca, Viiv.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Gigagen, Neophore, Nervgen, Novartis, Sunshine, Therapeutic Solutions, Tonix, Trevena, Viiv.
Since the very beginning of the COVID-19 pandemic, in addition to the attempts to rapidly develop a vaccine that was effective against current strains, researchers have been looking for a vaccine that could protect more broadly against multiple coronaviruses. That has prompted attempts to harness the potential of the more conserved S2 subunit of the spike protein via which SARS-CoV-2 enters human host cells.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Lexicon, MBX, Novartis, Soligenix, Veru.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 180, Abcellera, Aim, Akari, Alnylam, Altamira, Angion, Artizan, Assembly, Aurinia, Microviable, Pharmacyte, Spexis Sun, X4, Zyversa.
Genuine Biotech Co. Ltd.’s azvudine has been granted conditional approval by China’s NMPA for the treatment of COVID-19. The drug, first granted conditional approval from the NMPA to treat HIV-1-infected adults with high viral loads in July 2021, is the first domestically developed oral medicine approved to treat COVID-19 in China and was approved just 10 days after its application was submitted on July 15.
The controversy about the origins of the SARS-CoV-2 virus and the accusations that it escaped from the Wuhan Institute of Virology, or even that it was deliberately engineered there, could – possibly – be brought to a close by two papers published July 26, 2022.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Biogen, Cidara, Editas, ERC, Genuine, GBT, GSK, Inflarx, Ionis, LFB, Novavax, Sirnaomics.
RSS
